Effects of allopregnanolone on sedation in men, and in women on oral contraceptives

Psychoneuroendocrinology

Volumn 32, Issue 5, 2007, Pages 555-564

  van Broekhoven, F ^a   Backstrom T ^b   van Luijtelaar, G ^c   Buitelaar, J K ^a   Smits, P ^a   Verkes, R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Allopregnanolone; Humans; Neuroactive steroid; Saccadic eye movements

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG SENSITIVITY; ELECTROENCEPHALOGRAM; FATIGUE; FEMALE; FLUSHING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; RATING SCALE; SACCADIC EYE MOVEMENT; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE;

ADULT; AFFECT; ANESTHETICS; CONTRACEPTIVES, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; PREGNANOLONE; RECEPTORS, GABA-A; REFERENCE VALUES; SACCADES; SEX FACTORS;

EID: 34249021356     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.03.009     Document Type: Article

References (42)

1. Andreen L., Spigset O., Andersson A., Nyberg S., and Backstrom T. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas 54 (2006) 238-244
2. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 (1998) 963-987
3. Birzniece V., Turkmen S., Lindblad C., Zhu D., Johansson I.M., Backstrom T., and Wahlstrom G. GABA(A) receptor changes in acute allopregnanolone tolerance. Eur. J. Pharmacol. 535 (2006) 125-134
4. Bixo M., Andersson A., Winblad B., Purdy R.H., and Backstrom T. Progesterone, 5a-pregnane-3,20-dione and 3a-hydroxy-5a-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764 (1997) 173-178
5. Bond A., and Lader M. The use of analogue scales in rating subjective feelings. Br. J. Psychol. 47 (1974) 211-218
6. Brambilla F., Mellado C., Alciati A., Pisu M.G., Purdy R.H., Zanone S., Perini G., Serra M., and Biggio G. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Res. 135 (2005) 185-190
7. Coenen A.M., and van Luijtelaar E.L. Effects of diazepam and two beta-carbolines on epileptic activity and on EEG and behavior in rats with absence seizures. Pharmacol. Biochem. Behav. 32 (1989) 27-35
8. Crawley J.N., Glowa J.R., Majewska M.D., and Paul S.M. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398 (1986) 382-385
9. Droogleever Fortuyn H.A., van Broekhoven F., Span P.N., Backstrom T., Zitman F.G., and Verkes R.J. Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29 (2004) 1341-1344
10. Finn D.A., and Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 271 (1994) 164-170
11. Follesa P., Porcu P., Sogliano C., Cinus M., Biggio F., Mancuso L., Mostallino M.C., Paoletti A.M., Purdy R.H., Biggio G., and Concas A. Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42 (2002) 325-336
12. In: Ganong W. (Ed). Review of Medical Physiology (1991), Appleton and Lange, London
13. Glue P., Bailey J., Wilson S., Hudson A., and Nutt D.J. Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sci. 50 (1992) PL25-PL30
14. Holdstock L., Penland S.N., Morrow A.L., and de Wit H. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women. Psychopharmacology (Berl) 186 (2006) 442-450
15. Hommer D.W., Matsuo V., Wolkowitz O., Chrousos G., Greenblatt D.J., Weingartner H., and Paul S.M. Benzodiazepine sensitivity in normal human subjects. Arch. Gen. Psychiatry 43 (1986) 542-551
16. Hopfenbeck J.R., Cowley D.S., Radant A., Greenblatt D.J., and Roy-Byrne P.P. Effects of diphenhydramine on human eye movements. Psychopharmacology (Berl) 118 (1995) 280-286
17. Hosie A.M., Wilkins M.E., da Silva H.M.A., and Smart T.G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444 (2006) 486-489
18. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270 (1994) 1223-1229
19. Kurshan N., and Neill Epperson C. Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch. Womens Ment. Health 9 (2006) 1-14
20. Lancel M. Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22 (1999) 33-42
21. Lancel M., Faulhaber J., Schiffelholz T., Mathias S., and Deisz R.A. Muscimol and midazolam do not potentiate each other's effects on sleep EEG in the rat. J. Neurophysiol. 77 (1997) 1624-1629
22. Lancel M., Faulhaber J., Schiffelholz T., Romeo E., Di Michele F., Holsboer F., and Rupprecht R. Allopregnanolone affects sleep in a benzodiazepine-like fashion. J. Pharmacol. Exp. Ther. 282 (1997) 1213-1218
23. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
24. Norberg L., Backstrom T., and Wahlstrom G. Anaesthetic effects of pregnanolone in combination with allopregnanolone, thiopental, hexobarbital and flurazepam: an EEG study in the rat. Br. J. Anaesth. 82 (1999) 731-737
25. Orser B.A., Canning K.J., and Macdonald J.F. Mechanisms of general anesthesia. Curr. Opin. Anaesthesiol. 15 (2002) 427-433
26. Paoletti A.M., Lello S., Fratta S., Orru M., Ranuzzi F., Sogliano C., Concas A., Biggio G., and Melis G.B. Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol. Fertil. Steril. 81 (2004) 645-651
27. Purdy R.H., Moore Jr. P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., and Paul S.M. Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids 55 (1990) 290-296
28. Rahman M., Lindblad C., Johansson I.M., Backstrom T., and Wang M.D. Neurosteroid modulation of recombinant rat alpha5beta2gamma2L and alpha1beta2gamma2L GABA(A) receptors in Xenopus oocyte. Eur. J. Pharmacol. 547 (2006) 37-44
29. In: Rang H.P., Dale M., Ritter J.M., and Moore P.K. (Eds). Pharmacology (2003), Churchill Livingstone, London
30. Rapkin A.J., Biggio G., and Concas A. Oral contraceptives and neuroactive steroids. Pharmacol. Biochem. Behav. 84 (2006) 628-634
31. Romano-Torres M., Borja-Lascurain E., Chao-Rebolledo C., del-Rio-Portilla Y., and Corsi-Cabrera M. Effect of diazepam on EEG power and coherent activity: sex differences. Psychoneuroendocrinology 27 (2002) 821-833
32. Saletu B., Grunberger J., and Cepko H. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364. Int. J. Clin. Pharmacol. Ther. Toxicol. 25 (1987) 421-437
33. Schiller P.H., and Tehovnik E.J. Cortical inhibitory circuits in eye-movement generation. Eur. J. Neurosci. 18 (2003) 3127-3133
34. Schiller P.H., and Tehovnik E.J. Neural mechanisms underlying target selection with saccadic eye movements. Prog. Brain Res. 149 (2005) 157-171
35. Soderpalm A.H., Lindsey S., Purdy R.H., Hauger R., and Wit de H. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 29 (2004) 339-354
36. Sundstrom I., Nyberg S., and Backstrom T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17 (1997) 370-381
37. Timby E., Balgard M., Nyberg S., Spigset O., Andersson A., Porankiewicz-Asplund J., Purdy R.H., Zhu D., Backstrom T., and Poromaa I.S. Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 186 (2006) 414-424
38. Turkmen S., Lundgren P., Birzniece V., Zingmark E., Backstrom T., and Johansson I.M. 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur. J. Neurosci. 20 (2004) 1604-1612
39. van Broekhoven F., and Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berl) 165 (2003) 97-110
40. van Steveninck A.L., van Berckel B.N., Schoemaker R.C., Breimer D.D., van Gerven J.M., and Cohen A.F. The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. J. Psychopharmacol. 13 (1999) 10-17
41. Wang M., Seippel L., Purdy R.H., and Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J. Clin. Endocrinol. Metab. 81 (1996) 1076-1082
42. Wihlback A.C., Sundstrom-Poromaa I., and Backstrom T. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology (Berl) 186 (2006) 388-401